Autolus Therapeutics AUTL
NASDAQ AUTL
$1.32 +0.02 (+1.54%)
At close: Nov 10, 2026 · 4:00 PM EST

Autolus Therapeutics (AUTL) Gross Profit (2024 - 2026)

Updated

Autolus Therapeutics (AUTL) reported Gross Profit of $25.22 million for Q2 2026, compared with -$3.52 million a year earlier.

Analysis

Autolus Therapeutics (AUTL) Gross Profit (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Autolus Therapeutics' Gross Profit came in at $13.21 million; for FY2025, it was -$20.98 million.

  • By year, Gross Profit came in at -$1.27 million in FY2024 and $1.7 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Autolus Therapeutics 468.91 Mn -511.27 Mn 23.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 23.31 Mn
Jun 30, 2026 25.22 Mn
Mar 31, 2026 1.65 Mn
Dec 31, 2025 -1.04 Mn
Sep 30, 2025 -7.45 Mn
Jun 30, 2025 -3.52 Mn
Mar 31, 2025 -8.97 Mn
Dec 31, 2024 -11.36 Mn
Mar 31, 2024 10.09 Mn
API Access

Autolus Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=AUTL&period=max&api_key=YOUR_API_KEY